BMPR2 and pulmonary arterial hypertension: Induced pluripotent stem cells (iPSCs) from skin fibroblasts of PAH patients provide new insight into the molecular mechanism and reprogramming in BMPR2 mutation carriers and PAH patients for individualized therapy [109].